3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
29
Gastrointestinal
3
Plasma cell
2
Thoracic
1
Myeloid
1
CNS
1
Conditions
Myelodysplastic Syndromes
87
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
71
Leukemia, Myeloid, Acute
66
Leukemia
64
Myeloproliferative Disorders
60
Precursor Cell Lymphoblastic Leukemia-Lymphoma
45
Primary Myelofibrosis
39
Leukemia, Myeloid, Chronic-Phase
39
Leukemia, Myelomonocytic, Chronic
38
Polycythemia Vera
32
Lymphoma, Non-Hodgkin
29
Lymphoma
29
Multiple Myeloma
28
Leukemia, Lymphocytic, Chronic, B-Cell
28
Hodgkin Disease
27
Lymphoma, Large B-Cell, Diffuse
26
Lymphoma, Mantle-Cell
25
Burkitt Lymphoma
25
Leukemia, Myeloid, Accelerated Phase
24
Lymphoma, Large-Cell, Immunoblastic
23
Lymphoma, Follicular
23
Lymphoma, B-Cell, Marginal Zone
23
Blast Crisis
23
Thrombocythemia, Essential
20
Lymphoma, T-Cell, Cutaneous
19
Leukemia, Hairy Cell
18
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
17
Anemia, Refractory, with Excess of Blasts
17
Neoplasms, Plasma Cell
16
Myelodysplastic-Myeloproliferative Diseases
16
Interventions
N(4)-oleylcytosine arabinoside
1
Aspirin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Venous Thromboembolism
×
Myeloid
×
Clear all
NCT05198960
2026-03-20
AVAJAK
University Hospital, Brest
Phase 3
Recruiting
1,308 enrolled